Results 41 to 50 of about 10,142 (197)

Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?

Journal of Cardiovascular Development and Disease, 2021
Post-acute sequelae of SARS-CoV-2 (PASC), or long COVID syndrome, is emerging as a major health issue in patients with previous SARS-CoV-2 infection. Symptoms commonly experienced by patients include fatigue, palpitations, chest pain, dyspnea, reduced ...
Giandomenico Bisaccia, Fabrizio Ricci, Vittoria Recce, Antonio Serio, Giovanni Iannetti, Anwar A. Chahal, Marcus Ståhlberg, Mohammed Yunus Khanji, Artur Fedorowski, Sabina Gallina   +9 more
doaj   +1 more source

Structural and Functional Small Fiber Abnormalities in the Neuropathic Postural Tachycardia Syndrome [PDF]

, 2013
Objective: To define the neuropathology, clinical phenotype, autonomic physiology and differentiating features in individuals with neuropathic and non-neuropathic postural tachycardia syndrome (POTS).
Benson, Adam, Bonyhay, Istvan, Freeman, Roy, Gibbons, Christopher H., Wang, Ningshan   +4 more
core   +2 more sources

Orthostatic intolerance in chronic fatigue syndrome

Journal of Translational Medicine, 2019
Background Orthostatic intolerance (OI) is a significant problem for those with chronic fatigue syndrome (CFS). We aimed to characterize orthostatic intolerance in CFS and to study the effects of exercise on OI.
Richard Garner, James N. Baraniuk
doaj   +1 more source

Author response: Effects of orthostatic hypotension on cognition in Parkinson disease [PDF]

, 2017
OBJECTIVE: To investigate the relation between orthostatic hypotension (OH) and posture-mediated cognitive impairment in persons with Parkinson's disease (PD) without dementia.
Canova, Alexander O., Centi, Justin, Cronin-Golomb, Alice, Freeman, Roy, Gibbons, Christopher H., Neargarder, Sandy   +5 more
core   +1 more source

MEN2B Masquerading as Postural Orthostatic Tachycardia Syndrome

JACC: Case Reports, 2022
Multiple endocrine neoplasia type 2B is a genetic disorder characterized by pheochromocytoma, medullary thyroid carcinoma, and marfanoid features. Although hypertension and stress cardiomyopathy are known cardiovascular complications of pheochromocytoma, clinical presentation maybe subtle.
Khan, Ghazi, Giacona, John, Mirfakhraee, Sasan, Vernino, Steven, Vongpatanasin, Wanpen   +4 more
openaire   +2 more sources

Idiopathic osteoporosis, Ehlers–Danlos syndrome, postural orthostatic tachycardia syndrome, and mast cell activation disorder in a 27‐year‐old male patient: A unique case presentation

Clinical Case Reports, 2022
A young male patient presents with widespread pain and varying chronic inflammatory symptoms for three years and idiopathic low bone density for more than ten years.
Cameron Rattray
doaj   +1 more source

Physiological assessment of orthostatic intolerance in chronic fatigue syndrome

Journal of Translational Medicine, 2022
Background Orthostatic intolerance-OI is common in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-ME/CFS. We used a 10-min passive vertical lean test as orthostatic challenge-OC and measured changes in vitals and end tidal CO2 (eTCO2).
Benjamin H. Natelson, Jin-Mann S. Lin, Michelle Blate, Sarah Khan, Yang Chen, Elizabeth R. Unger   +5 more
doaj   +1 more source

Occupational Therapy Strategies for Postural Orthostatic Tachycardia Syndrome [PDF]

, 2023
Effectiveness of occupational therapy strategies with adults with postural orthostatic tachycardia ...
Bennett, Emily, Dew, Mackenzie, Geissler, Rachel, Jamerson, Marjorie, Mendez, Laura, Tockey, Hunter, Weldon, Summer   +6 more
core   +2 more sources

Exercise in the postural orthostatic tachycardia syndrome [PDF]

Autonomic Neuroscience, 2015
Patients with the Postural Orthostatic Tachycardia Syndrome (POTS) have orthostatic intolerance, as well as exercise intolerance. Peak oxygen uptake (VO2peak) is generally lower in these patients compared with healthy sedentary individuals, suggesting a lower physical fitness level.
Qi, Fu, Benjamin D, Levine
openaire   +2 more sources

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source